|4Jun 2, 5:21 PM ET

CUMBERLAND PHARMACEUTICALS INC 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Jun 2, 2017

Insider Transaction Report

Form 4
Period: 2017-05-31
Bonner Michael
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-05-31$6.95/sh+300$2,08514,947 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION